Motyka, J.; Gacuta, E.; Kicman, A.; Kulesza, M.; Ławicki, P.; Ławicki, S.
Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer. J. Clin. Med. 2022, 11, 6694.
https://doi.org/10.3390/jcm11226694
AMA Style
Motyka J, Gacuta E, Kicman A, Kulesza M, Ławicki P, Ławicki S.
Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer. Journal of Clinical Medicine. 2022; 11(22):6694.
https://doi.org/10.3390/jcm11226694
Chicago/Turabian Style
Motyka, Joanna, Ewa Gacuta, Aleksandra Kicman, Monika Kulesza, Paweł Ławicki, and Sławomir Ławicki.
2022. "Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer" Journal of Clinical Medicine 11, no. 22: 6694.
https://doi.org/10.3390/jcm11226694
APA Style
Motyka, J., Gacuta, E., Kicman, A., Kulesza, M., Ławicki, P., & Ławicki, S.
(2022). Plasma Levels of CXC Motif Chemokine 1 (CXCL1) and Chemokine 8 (CXCL8) as Diagnostic Biomarkers in Luminal A and B Breast Cancer. Journal of Clinical Medicine, 11(22), 6694.
https://doi.org/10.3390/jcm11226694